Bolt BiotherapeuticsBOLT
13F holders, Q1 2024 (March 31)39holders
3famous investors
$1.40avg. 13F price*
At the end of Q1 2024, 39 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings. The largest holders were Vivo Capital, LLC ($4.9M), Tang Capital Management LLC ($4.8M) and Sofinnova Investments, Inc. ($3.9M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702104
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $22K |
| Exits | 3 | $196K |
Ownership 39 holders
| Vivo Capital, LLC | 0.39% | No change | 3,521,291 | $4.9M |
| Tang Capital Management LLC | 0.50% | Reduce -6.4% | 3,420,000 | $4.8M |
| Sofinnova Investments, Inc. | 0.23% | No change | 2,754,437 | $3.9M |
| Citadel Advisors | 0.00% | Reduce -1.8% | 2,415,728 | $3.4M |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.70% | No change | 1,891,467 | $2.6M |
| Newtyn Management, LLC | 0.48% | Add +9.4% | 1,700,000 | $2.4M |
| Orbimed Advisors LLC | 0.04% | No change | 1,541,000 | $2.2M |
| Nan Fung Group Holdings Ltd | 1.51% | No change | 1,166,952 | $1.6M |
| Samsara Biocapital, LLC | 0.23% | No change | 1,049,153 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +11.4% | 1,037,603 | $1.5M |
| Board of Trustees of The Leland Stanford Junior University | 0.09% | No change | 719,546 | $1.0M |
| Acuitas Investments, LLC | 0.37% | Add +12.7% | 517,952 | $725K |
| Renaissance Technologies | 0.00% | Add +16.3% | 517,637 | $725K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 500,000 | $700K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.7% | 347,567 | $487K |
| BlackRock Inc. | 0.00% | Reduce -0.9% | 254,958 | $357K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 111,200 | $156K |
| Marquette Asset Management, LLC | 0.02% | No change | 96,673 | $135K |
| FMR LLC | 0.00% | Reduce -0.4% | 78,899 | $110K |
| Squarepoint Ops LLC | 0.00% | Reduce -2.2% | 78,020 | $109K |
| State Street Corp. | 0.00% | No change | 47,437 | $66K |
| Millennium Management | 0.00% | Reduce -2.2% | 45,956 | $64K |
| Northern Trust Corp. | 0.00% | No change | 41,005 | $57K |
| Prudential Financial Inc. | 0.00% | Add +188.5% | 35,200 | $49K |
| Morgan Stanley | 0.00% | Reduce -68.9% | 24,687 | $35K |
| Two Sigma Securities, LLC | 0.00% | Reduce -62.9% | 23,814 | $33K |
| Osaic Holdings, Inc. | 0.00% | Add +277.1% | 15,000 | $21K |
| XTX Topco Ltd | 0.00% | Reduce -33.0% | 12,826 | $18K |
| UBS Group AG | 0.00% | Add +59.1% | 12,171 | $17K |
| Virtu Financial LLC | 0.00% | New | 10,938 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -32.7% | 5,546 | $8K |
| ADAR1 Capital Management, LLC | 0.00% | New | 5,000 | $7K |
| JPMorgan Chase & Co. | 0.00% | No change | 840 | $1K |
| Bank of America Corp. | 0.00% | No change | 628 | $879 |
| Wells Fargo & Company | 0.00% | Add +1.9% | 211 | $295 |
| Barclays PLC | 0.00% | No change | 139 | $195 |
| Salem Investment Counselors Inc. | 0.00% | No change | 40 | $56 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -99.8% | 1 | $0 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.